Entity Details

Primary name ZFY27_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ5T4F4
EntryNameZFY27_HUMAN
FullNameProtrudin
TaxID9606
Evidenceevidence at protein level
Length411
SequenceStatuscomplete
DateCreated2006-07-11
DateModified2021-06-02

Ontological Relatives

GenesZFYVE27

GO terms

Show/Hide Table
GOName
GO:0005654 nucleoplasm
GO:0005783 endoplasmic reticulum
GO:0005829 cytosol
GO:0016192 vesicle-mediated transport
GO:0030176 integral component of endoplasmic reticulum membrane
GO:0030424 axon
GO:0030425 dendrite
GO:0031175 neuron projection development
GO:0032584 growth cone membrane
GO:0042802 identical protein binding
GO:0043231 intracellular membrane-bounded organelle
GO:0043621 protein self-association
GO:0045773 positive regulation of axon extension
GO:0046872 metal ion binding
GO:0048011 neurotrophin TRK receptor signaling pathway
GO:0055038 recycling endosome membrane
GO:0071782 endoplasmic reticulum tubular network
GO:0071787 endoplasmic reticulum tubular network formation
GO:0072659 protein localization to plasma membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Cell projection
Endoplasmic reticulum membrane
Recycling endosome membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000306 FYVE zinc fingerDomainDomain
IPR011011 Zinc finger, FYVE/PHD-typeFamilyHomologous superfamily
IPR013083 Zinc finger, RING/FYVE/PHD-typeFamilyHomologous superfamily
IPR017455 Zinc finger, FYVE-relatedDomainDomain
IPR042405 ProtrudinFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
610244 OMIMSpastic paraplegia 33, autosomal dominant (SPG33)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. The disease is caused by variants affecting the gene represented in this entry. According to PubMed:18606302, the properties of the variant Val-191 and its frequency in some populations raise doubts on the implication of that gene in the disease.

Interactions

30 interactions

InteractorPartnerSourcesPublicationsLink
ZFY27_HUMANFKBP8_HUMANUniProt17082457 18459960 details
ZFY27_HUMANVAPA_HUMANBioGRID, IntAct, UniProt19289470 28514442 details
ZFY27_HUMANYIF1A_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANGIMA5_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANSTX7_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANSAC1_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANPP4P2_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANTM14C_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANORML1_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANTSN2_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANZNT8_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANTM128_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANIR3IP_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANS66A2_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANSC22A_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANGIMA1_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANOTOP3_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANTM243_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANTMM65_HUMANBioGRID, IntAct32296183 details
ZFY27_HUMANA4_HUMANBioGRID21832049 details
ZFY27_HUMANRB11A_HUMANUniProt17082457 details
ZFY27_HUMANVAPB_HUMANUniProt19289470 details
ZFY27_HUMANRAB7A_HUMANDIP25855459 details
ZFY27_HUMANATLA3_HUMANUniProt23969831 details
ZFY27_HUMANREEP5_HUMANBioGRID, UniProt23969831 34079125 details
ZFY27_HUMANATLA2_HUMANUniProt23969831 details
ZFY27_HUMANATLA1_HUMANUniProt23969831 details
ZFY27_HUMANZFY27_HUMANUniProt23969831 details
ZFY27_HUMANREEP1_HUMANUniProt23969831 details
ZFY27_HUMANSPAST_HUMANUniProt23969831 details